Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 50, 2021 - Issue 7
53
Views
0
CrossRef citations to date
0
Altmetric
Letter To The Editor

Letter from the Editor: 2021

References

  • Baric A, Brcic L, Gracan S, Skrabic V, Brekalo M, Simunac M, Lovric VT, Anic I, Barbalic M, Zemunik T, et al. 2019. Thyroglobulin antibodies are associated with symptom burden in patients with Hashimoto’s thyroiditis: a cross-sectional study. Immunol Invest. 48(2):198–209. doi:10.1080/08820139.2018.1529040
  • Elwan N, Salem ML, Kobtan A, El-Kalla F, Mansour L, Yousef M, Al-Sabbagh A, Zidan AA, Abd-Elsalam S. 2018. High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients. Immunol Invest. 47(2):169–80.
  • Hofman K, Shenoy GN, Chak V, Balu-Iyer SV. 2021. Pharmaceutical aspects and clinical evaluation of COVID-19 vaccines. Immunol Invest. 1–37. doi:10.1080/08820139.2021.1904977
  • Jabalameli N, Rajabi F, Firooz A, Rezaei N. 2021. The overlap between genetic susceptibility to COVID-19 and skin diseases. Immunol Invest. 1–8. doi:10.1080/08820139.2021.1876086
  • Kailashiya V, Singh U, Rana R, Singh NK, Dash D, Kailashiya J. 2019. Regulatory T cells and their association with serum markers and symptoms in systemic lupus erythematosus and rheumatoid arthritis. Immunol Invest. 48(1):64–78.
  • Kerboua KE. 2021. NLR: a cost-effective nomogram to guide therapeutic interventions in COVID-19. Immunol Invest. 50(1):92–100.
  • Kirkwood KL. 2018. Inflammaging. Immunol Invest. 47(8):770–73.
  • Labzin LI, Heneka MT, Latz E. 2018. Innate immunity and neurodegeneration. Annu Rev Med. 69437–49. doi:10.1146/annurev-med-050715-104343
  • Lee GJ, Chu KB, Inn KS, Moon EK, Quan FS. 2020. Vaccine efficacy induced by 2009 pandemic H1N1 virus-like particles differs from that induced by split influenza virus. Immunol Invest. 49(7):781–93.
  • Li S, Qiao Y, Xu Y, Li P, Nie J, Zhao Q, Chai W, Shi Y, Kong W, Shan Y. 2020. Identification of linear peptide immunogens with verified broad-spectrum immunogenicity from the conserved regions within the hemagglutinin stem domain of H1N1 influenza virus. Immunol Invest. 1–14. doi:10.1080/08820139.2020.1834579
  • Li S, Shi R, Tian L, Chen J, Li X, Huang L, Yang Z. 2019. The relationship of COX-2 gene polymorphisms and susceptibility to Kawasaki disease in Chinese population. Immunol Invest. 48(2):181–89.
  • Liu LN, Mao YM, Zhao CN, Wang H, Yuan FF, Li XM, Pan HF. 2019. Circulating levels of osteoprotegerin, osteocalcin and osteopontin in patients with rheumatoid arthritis: a systematic review and meta-analysis. Immunol Invest. 48(2):107–20.
  • Mahmoodpoor A, Hamishehkar H, Shadvar K, Ostadi Z, Sanaie S, Saghaleini SH, Nader ND. 2019. The effect of intravenous selenium on oxidative stress in critically ill patients with acute respiratory distress syndrome. Immunol Invest. 48(2):147–59.
  • Mathis D, Shoelson SE. 2011. Immunometabolism: an emerging frontier. Nat Rev Immunol. 11(2):81.
  • Moon EK, Kang HJ, Chu KB, Lee SH, Lee DH, Soh Y, Quan FS. 2019. Immune correlates of protection induced by virus-like particles containing 2009 H1N1 pandemic influenza HA, NA or M1 proteins. Immunol Invest. 48(4):355–66.
  • Morisaki T, Hikichi T, Onishi H, Morisaki T, Kubo M, Hirano T, Yoshimura S, Kiyotani K, Nakamura Y. 2021. Intranodal administration of neoantigen peptide-loaded dendritic cell vaccine elicits epitope-specific T cell responses and clinical effects in a patient with chemorefractory ovarian cancer with malignant ascites. Immunol Invest. 50(5):562–79.
  • Nuccetelli M, Pieri M, Gisone F, Bernardini S. 2020. Combined anti-SARS-CoV-2 IgA, IgG, and IgM detection as a better strategy to prevent second infection spreading waves. Immunol Invest. 1–13. doi:10.1080/08820139.2020.1823407
  • Ostrov BE, Amsterdam D. 2021a. Immunological investigations thematic: editors’ introduction. Immunol Invest. 1–3. doi:10.1080/08820139.2021.1945085
  • Ostrov BE, Amsterdam D. 2021b. Interplay of anti-viral vaccines with biologic agents and immunomodulators in individuals with autoimmune and autoinflammatory diseases. Immunol Invest. 1–24. doi:10.1080/08820139.2021.1900863
  • Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al.. 2017. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 377(12):1119–31. doi:10.1056/NEJMoa1707914
  • Rokhafrooz S, Ghadiri A, Ghandil P, Ghafourian M, Hossaini SH, Daraei N, Najafian M, Rouhizadeh A. 2018. Association between HLA-G 14bp gene polymorphism and serum sHLA-G protein concentrations in preeclamptic patients and normal pregnant women. Immunol Invest. 47(6):558–68.
  • Saleh A, Sultan A, Elashry MA, Farag A, Mortada MI, Ghannam MA, Saed AM, Ghoneem S. 2020a. Association of TNF-alpha G-308 a promoter polymorphism with the course and outcome of COVID-19 patients. Immunol Invest. 1–12. doi:10.1080/08820139.2020.1851709
  • Saleh R, Taha RZ, Sasidharan Nair V, Toor SM, Alajez NM, Elkord E. 2020b. Transcriptomic profiling of circulating HLA-DR(-) myeloid cells, compared with HLA-DR(+) myeloid antigen-presenting cells. Immunol Invest. 1–12. doi:10.1080/08820139.2020.1795875
  • Shabani SH, Kardani K, Milani A, Bolhassani A. 2021. In silico and in vivo analysis of HIV-1 rev regulatory protein for evaluation of a multiepitope-based vaccine candidate. Immunol Invest. 1–28. doi:10.1080/08820139.2020.1867163
  • Shohan M, Sabzevary-Ghahfarokhi M, Bagheri N, Shirzad H, Rahimian G, Soltani A, Ghatreh-Samani M, Deris F, Tahmasbi K, Shahverdi E, et al.. 2018. Intensified Th9 response is associated with the immunopathogenesis of active ulcerative colitis. Immunol Invest. 47(7):700–11. doi:10.1080/08820139.2018.1486411
  • Sullivan ZA, Khoury-Hanold W, Lim J, Smillie C, Biton M, Reis BS, Zwick RK, Pope SD, Israni-Winger K, Parsa R, et al.. 2021. Gamma delta T cells regulate the intestinal response to nutrient sensing. Science. 371:6535.
  • Zhang B, Li XL, Zhao CR, Pan CL, Zhang Z. 2018. Interleukin-6 as a predictor of the risk of cardiovascular disease: a meta-analysis of prospective epidemiological studies. Immunol Invest. 47(7):689–99.
  • Zhang M, Yang J, Zhou J, Gao W, Zhang Y, Lin Y, Wang H, Ruan Z, Ni B. 2019. Prognostic values of CD38(+)CD101(+)PD1(+)CD8(+) T cells in pancreatic cancer. Immunol Invest. 48(5):466–79.
  • Zhou Z, Tian Z, Zhang M, Zhang Y, Ni B, Hao F. 2018. Upregulated IL-1 receptor-associated kinase 1 (IRAK1) in systemic lupus erythematosus: IRAK1 inhibition represses Th17 differentiation with therapeutic potential. Immunol Invest. 47(5):468–83.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.